Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Device Directives out for comments in EU states

This article was originally published in Clinica

Executive Summary

Several countries are already taking part in a pilot programme European Commission initiative whereby they have put forward their draft national transpositions of the revised Medical Devices Directive and Active Implantable Medical Devices Directive for pre-adoption screening. This revised Directive must be transposed into national law by December 21 2008 and must be fully applied by March 21 2010. The initiative gives the European Commission, member states, industry and even individuals the opportunity to comment, electronically, on the draft laws in an attempt to iron out any discrepancies. This, the Commission says should obviate "costly and controversial infringement proceedings" which could otherwise only be launched after the texts had become law. The other great advantage of this pre-adoption screening procedure is that is "spreads the word" on best practices, which then become a model for regulatory initiatives in other countries.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT046726

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel